Free Trial
→ Watch This Robotics Demo Before July 23rd (From Brownstone Research) (Ad) Buy BOW Stock  Free BOW Stock Alerts

Bowhead Specialty (BOW) Financials

Bowhead Specialty logo
$41.31 +1.31 (+3.28%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$41.34 +0.02 (+0.06%)
As of 05/2/2025 04:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Bowhead Specialty

Annual Income Statements for Bowhead Specialty

This table shows Bowhead Specialty's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 11 25 38
Consolidated Net Income / (Loss)		 11 25 38
Net Income / (Loss) Continuing Operations		 11 25 38
Total Pre-Tax Income 		15 32 51
Total Operating Income		 30 54 88
Total Gross Profit		 76 117 178
Total Revenue		 188 283 426
Operating Revenue		 188 283 426
Total Cost of Revenue		 112 166 248
Operating Cost of Revenue		 112 166 248
Total Operating Expenses		 46 63 89
Other Operating Expenses / (Income)		 46 63 89
Total Other Income / (Expense), net		 -15 -22 -38
Interest Expense		 0.00 0.00 0.73
Other Income / (Expense), net		 -15 -22 -37
Income Tax Expense		 3.41 7.07 12
Basic Earnings per Share		 $0.47 $1.04 $1.31
Weighted Average Basic Shares Outstanding		 24M 24M 29.26M
Diluted Earnings per Share		 $0.47 $1.04 $1.29
Weighted Average Diluted Shares Outstanding		 24M 24M 29.68M
Weighted Average Basic & Diluted Shares Outstanding		 - - 32.66M

Quarterly Income Statements for Bowhead Specialty

This table shows Bowhead Specialty's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q2 2024 Q3 2024
Period end date 6/30/2023 9/30/2023 6/30/2024 9/30/2024
Net Income / (Loss) Attributable to Common Shareholders		 6.56 8.71 5.53 12
Consolidated Net Income / (Loss)		 6.56 8.71 5.53 12
Net Income / (Loss) Continuing Operations		 6.56 8.71 5.53 12
Total Pre-Tax Income 		8.46 11 7.41 16
Total Operating Income		 13 17 17 27
Total Gross Profit		 28 33 40 49
Total Revenue		 65 76 99 117
Operating Revenue		 65 76 99 117
Total Cost of Revenue		 37 43 59 68
Operating Cost of Revenue		 37 43 59 68
Total Operating Expenses		 15 16 23 22
Other Operating Expenses / (Income)		 15 16 23 22
Total Other Income / (Expense), net		 -4.97 -5.66 -9.62 -11
Interest Expense		 0.00 0.00 0.22 0.25
Other Income / (Expense), net		 -4.97 -5.66 -9.39 -10
Income Tax Expense		 1.91 2.56 1.88 3.73
Basic Earnings per Share		 $0.27 $0.36 $0.20 $0.37
Weighted Average Basic Shares Outstanding		 24M 24M 27.65M 32.66M
Diluted Earnings per Share		 $0.27 $0.36 $0.20 $0.36
Weighted Average Diluted Shares Outstanding		 24M 24M 27.77M 33.26M
Weighted Average Basic & Diluted Shares Outstanding		 - - 32.66M 32.66M

Annual Cash Flow Statements for Bowhead Specialty

This table details how cash moves in and out of Bowhead Specialty's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -6.81 39 102
Net Cash From Operating Activities		 182 236 294
Net Cash From Continuing Operating Activities		 182 236 294
Net Income / (Loss) Continuing Operations		 11 25 38
Consolidated Net Income / (Loss)		 11 25 38
Depreciation Expense		 0.73 2.27 3.87
Amortization Expense		 -0.07 -2.85 -3.51
Non-Cash Adjustments To Reconcile Net Income		 175 224 267
Changes in Operating Assets and Liabilities, net		 -5.31 -13 -11
Net Cash From Investing Activities		 -187 -275 -326
Net Cash From Continuing Investing Activities		 -187 -275 -326
Purchase of Property, Plant & Equipment		 -3.97 -3.82 -3.11
Purchase of Investments		 -198 -367 -613
Sale and/or Maturity of Investments		 15 96 290
Net Cash From Financing Activities		 -1.00 78 134
Net Cash From Continuing Financing Activities		 -1.00 78 134
Payment of Dividends		 -25 0.00 0.00
Issuance of Common Equity		 0.00 0.00 131
Other Financing Activities, net		 24 78 2.90
Cash Income Taxes Paid		 5.29 14 16

Quarterly Cash Flow Statements for Bowhead Specialty

This table details how cash moves in and out of Bowhead Specialty's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q3 2024 Q4 2024
Period end date 9/30/2023 12/31/2023 9/30/2024 12/31/2024
Net Change in Cash & Equivalents		 52 -15 -37 60
Net Cash From Operating Activities		 88 61 119 61
Net Cash From Continuing Operating Activities		 88 62 119 62
Net Income / (Loss) Continuing Operations		 8.71 4.78 12 14
Consolidated Net Income / (Loss)		 8.71 4.78 12 14
Depreciation Expense		 0.78 0.81 1.05 1.10
Amortization Expense		 -0.76 -1.01 -0.86 -0.58
Non-Cash Adjustments To Reconcile Net Income		 -79 219 23 292
Changes in Operating Assets and Liabilities, net		 158 -161 84 -244
Net Cash From Investing Activities		 -59 -101 -157 -1.14
Net Cash From Continuing Investing Activities		 -59 -101 -157 -1.14
Purchase of Property, Plant & Equipment		 -1.09 -0.92 -1.01 -0.51
Purchase of Investments		 -62 -128 -239 -145
Sale and/or Maturity of Investments		 3.86 28 83 144
Net Cash From Financing Activities		 22 25 - 0.06
Net Cash From Continuing Financing Activities		 22 25 - 0.06
Other Financing Activities, net		 22 25 - 0.06

Annual Balance Sheets for Bowhead Specialty

This table presents Bowhead Specialty's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024
Period end date 12/31/2023 12/31/2024
Total Assets		 1,028 1,654
Total Current Assets		 313 559
Cash & Equivalents		 118 97
Restricted Cash		 1.70 125
Short-Term Investments		 13 18
Current Deferred & Refundable Income Taxes		 1.11 0.59
Other Current Assets		 178 319
Plant, Property, & Equipment, net		 7.60 6.85
Total Noncurrent Assets		 717 1,098
Noncurrent Deferred & Refundable Income Taxes		 14 20
Other Noncurrent Operating Assets		 702 1,078
Total Liabilities & Shareholders' Equity		 1,028 1,654
Total Liabilities		 836 1,284
Total Current Liabilities		 831 1,275
Accrued Expenses		 15 18
Current Deferred & Payable Income Tax Liabilities		 0.04 1.57
Other Current Liabilities		 816 1,256
Total Noncurrent Liabilities		 4.51 8.65
Other Noncurrent Operating Liabilities		 4.51 8.65
Commitments & Contingencies		 0.00 0.00
Redeemable Noncontrolling Interest		 0.00 0.27
Total Equity & Noncontrolling Interests		 192 370
Total Preferred & Common Equity		 192 370
Total Common Equity		 192 370
Common Stock		 179 318
Retained Earnings		 25 63
Accumulated Other Comprehensive Income / (Loss)		 -11 -11

Quarterly Balance Sheets for Bowhead Specialty

This table presents Bowhead Specialty's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024
Period end date 6/30/2024 9/30/2024
Total Assets		 1,395 1,548
Total Current Assets		 481 451
Cash & Equivalents		 180 133
Restricted Cash		 18 29
Short-Term Investments		 19 17
Current Deferred & Refundable Income Taxes		 1.32 0.33
Other Current Assets		 262 272
Plant, Property, & Equipment, net		 7.48 7.44
Total Noncurrent Assets		 919 1,099
Noncurrent Deferred & Refundable Income Taxes		 17 16
Other Noncurrent Operating Assets		 902 1,083
Total Liabilities & Shareholders' Equity		 1,395 1,548
Total Liabilities		 1,055 1,183
Total Current Liabilities		 1,037 1,176
Accrued Expenses		 11 15
Current Deferred & Payable Income Tax Liabilities		 0.03 0.03
Other Current Liabilities		 1,025 1,161
Total Noncurrent Liabilities		 18 7.29
Other Noncurrent Operating Liabilities		 18 7.29
Commitments & Contingencies		 0.00 0.00
Redeemable Noncontrolling Interest		 0.05 0.16
Total Equity & Noncontrolling Interests		 340 365
Total Preferred & Common Equity		 340 365
Total Common Equity		 340 365
Common Stock		 315 317
Retained Earnings		 37 49
Accumulated Other Comprehensive Income / (Loss)		 -12 -1.29

Annual Metrics and Ratios for Bowhead Specialty

This table displays calculated financial ratios and metrics derived from Bowhead Specialty's official financial filings.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - -
Revenue Growth		 0.00% 51.06% 50.20%
EBITDA Growth		 0.00% 105.87% 63.69%
EBIT Growth		 0.00% 119.05% 59.61%
NOPAT Growth		 0.00% 82.58% 59.94%
Net Income Growth		 0.00% 122.52% 52.69%
EPS Growth		 0.00% 121.28% 24.04%
Operating Cash Flow Growth		 0.00% 30.05% 24.58%
Free Cash Flow Firm Growth		 0.00% 0.00% 75.66%
Invested Capital Growth		 0.00% 0.00% 108.23%
Revenue Q/Q Growth		 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00%
Profitability Metrics		 - - -
Gross Margin		 40.43% 41.33% 41.71%
EBITDA Margin		 8.17% 11.13% 12.13%
Operating Margin		 15.91% 18.93% 20.78%
EBIT Margin		 7.81% 11.33% 12.04%
Profit (Net Income) Margin		 6.00% 8.84% 8.98%
Tax Burden Percent		 76.78% 77.99% 75.68%
Interest Burden Percent		 100.00% 100.00% 98.59%
Effective Tax Rate		 23.22% 22.01% 24.32%
Return on Invested Capital (ROIC)		 0.00% 123.73% 64.20%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 150.74% 80.41%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -97.65% -50.60%
Return on Equity (ROE)		 0.00% 26.08% 13.60%
Cash Return on Invested Capital (CROIC)		 0.00% -76.27% -6.02%
Operating Return on Assets (OROA)		 0.00% 3.12% 3.82%
Return on Assets (ROA)		 0.00% 2.44% 2.85%
Return on Common Equity (ROCE)		 0.00% 26.08% 13.59%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 13.04% 10.33%
Net Operating Profit after Tax (NOPAT)		 23 42 67
NOPAT Margin		 12.22% 14.77% 15.72%
Net Nonoperating Expense Percent (NNEP)		 0.00% -27.01% -16.21%
Return On Investment Capital (ROIC_SIMPLE)		 - 21.79% 18.08%
Cost of Revenue to Revenue		 59.57% 58.67% 58.29%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 24.51% 22.39% 20.94%
Earnings before Interest and Taxes (EBIT)		 15 32 51
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 15 32 52
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 0.00 0.67 3.13
Price to Tangible Book Value (P/TBV)		 0.00 0.67 3.13
Price to Revenue (P/Rev)		 0.68 0.45 2.73
Price to Earnings (P/E)		 11.37 5.11 30.33
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 8.79% 19.57% 3.30%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 6.54
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 2.16
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 17.84
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 17.96
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 13.76
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 3.13
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00
Financial Leverage		 0.00 -0.65 -0.63
Leverage Ratio		 0.00 5.35 4.77
Compound Leverage Factor		 0.00 5.35 4.70
Debt to Total Capital		 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.07%
Common Equity to Total Capital		 0.00% 100.00% 99.93%
Debt to EBITDA		 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00
Altman Z-Score		 0.00 -0.10 0.44
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.05%
Liquidity Ratios		 - - -
Current Ratio		 0.00 0.38 0.44
Quick Ratio		 0.00 0.16 0.09
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 0.00 -26 -6.28
Operating Cash Flow to CapEx		 4,573.11% 6,185.52% 9,456.52%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 -8.66
Operating Cash Flow to Interest Expense		 0.00 0.00 405.91
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 401.62
Efficiency Ratios		 - - -
Asset Turnover		 0.00 0.28 0.32
Accounts Receivable Turnover		 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 37.28 58.93
Accounts Payable Turnover		 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00
Capital & Investment Metrics		 - - -
Invested Capital		 0.00 68 141
Invested Capital Turnover		 0.00 8.38 4.08
Increase / (Decrease) in Invested Capital		 0.00 68 73
Enterprise Value (EV)		 0.00 -5.25 921
Market Capitalization		 128 128 1,160
Book Value per Share		 $0.00 $8.00 $11.33
Tangible Book Value per Share		 $0.00 $8.00 $11.33
Total Capital		 0.00 192 370
Total Debt		 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00
Net Debt		 0.00 -133 -240
Capital Expenditures (CapEx)		 3.97 3.82 3.11
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -652 -956
Debt-free Net Working Capital (DFNWC)		 0.00 -519 -716
Net Working Capital (NWC)		 0.00 -519 -716
Net Nonoperating Expense (NNE)		 12 17 29
Net Nonoperating Obligations (NNO)		 0.00 -124 -230
Total Depreciation and Amortization (D&A)		 0.66 -0.58 0.36
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -230.05% -224.55%
Debt-free Net Working Capital to Revenue		 0.00% -183.03% -168.27%
Net Working Capital to Revenue		 0.00% -183.03% -168.27%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $1.31
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 29.26M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $1.29
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 29.68M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 32.66M
Normalized Net Operating Profit after Tax (NOPAT)		 23 42 67
Normalized NOPAT Margin		 12.22% 14.77% 15.72%
Pre Tax Income Margin		 7.81% 11.33% 11.87%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 0.00 0.00 70.70
NOPAT to Interest Expense		 0.00 0.00 92.32
EBIT Less CapEx to Interest Expense		 0.00 0.00 66.41
NOPAT Less CapEx to Interest Expense		 0.00 0.00 88.03
Payout Ratios		 - - -
Dividend Payout Ratio		 222.10% 0.00% 0.00%
Augmented Payout Ratio		 222.10% 0.00% 0.00%

Quarterly Metrics and Ratios for Bowhead Specialty

This table displays calculated financial ratios and metrics derived from Bowhead Specialty's official financial filings.

Metric Q2 2023 Q3 2023 Q2 2024 Q3 2024
Period end date 6/30/2023 9/30/2023 6/30/2024 9/30/2024
Growth Metrics		 - - - -
Revenue Growth		 0.00% 0.00% 51.10% 53.45%
EBITDA Growth		 0.00% 0.00% -9.76% 44.10%
EBIT Growth		 0.00% 0.00% -9.76% 42.68%
NOPAT Growth		 0.00% 0.00% 22.18% 55.14%
Net Income Growth		 0.00% 0.00% -15.59% 38.86%
EPS Growth		 0.00% 0.00% -25.93% 0.00%
Operating Cash Flow Growth		 0.00% 0.00% 0.00% 35.32%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth		 0.00% 16.26% 0.00% 18.06%
EBITDA Q/Q Growth		 0.00% 33.36% 0.00% 112.97%
EBIT Q/Q Growth		 0.00% 33.14% 0.00% 110.53%
NOPAT Q/Q Growth		 0.00% 25.73% 0.00% 59.64%
Net Income Q/Q Growth		 0.00% 32.85% 0.00% 118.54%
EPS Q/Q Growth		 0.00% 33.33% 0.00% 80.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% -44.43%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 45.87%
Profitability Metrics		 - - - -
Gross Margin		 42.85% 43.76% 40.32% 41.91%
EBITDA Margin		 12.93% 14.83% 7.72% 13.92%
Operating Margin		 20.52% 22.24% 17.21% 22.74%
EBIT Margin		 12.93% 14.80% 7.72% 13.76%
Profit (Net Income) Margin		 10.01% 11.44% 5.59% 10.36%
Tax Burden Percent		 77.48% 77.31% 74.67% 76.43%
Interest Burden Percent		 100.00% 100.00% 97.07% 98.43%
Effective Tax Rate		 22.52% 22.69% 25.33% 23.57%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 0.00% 0.00% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 10 13 13 20
NOPAT Margin		 15.90% 17.19% 12.85% 17.38%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% -6.99% -9.72%
Cost of Revenue to Revenue		 57.15% 56.24% 59.68% 58.09%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 22.33% 21.52% 23.11% 19.17%
Earnings before Interest and Taxes (EBIT)		 8.46 11 7.63 16
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 8.46 11 7.63 16
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.56 2.51
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.56 2.51
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 3.76
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - -
Debt to Equity		 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00
Financial Leverage		 0.00 0.00 -0.60 -0.46
Leverage Ratio		 0.00 0.00 4.10 4.24
Compound Leverage Factor		 0.00 0.00 3.98 4.18
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.01% 0.04%
Common Equity to Total Capital		 0.00% 0.00% 99.99% 99.96%
Debt to EBITDA		 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00
Altman Z-Score		 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - -
Current Ratio		 0.00 0.00 0.46 0.38
Quick Ratio		 0.00 0.00 0.19 0.13
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 -122 -176
Operating Cash Flow to CapEx		 0.00% 8,105.69% 0.00% 11,873.66%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 -543.09 -697.22
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 474.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 470.01
Efficiency Ratios		 - - - -
Asset Turnover		 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - -
Invested Capital		 0.00 0.00 134 196
Invested Capital Turnover		 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 0.00 0.00 134 196
Enterprise Value (EV)		 0.00 0.00 -27 736
Market Capitalization		 128 128 191 915
Book Value per Share		 $0.00 $0.00 $12.29 $11.17
Tangible Book Value per Share		 $0.00 $0.00 $12.29 $11.17
Total Capital		 0.00 0.00 340 365
Total Debt		 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00
Net Debt		 0.00 0.00 -218 -179
Capital Expenditures (CapEx)		 0.00 1.09 0.00 1.01
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 0.00 -774 -904
Debt-free Net Working Capital (DFNWC)		 0.00 0.00 -556 -725
Net Working Capital (NWC)		 0.00 0.00 -556 -725
Net Nonoperating Expense (NNE)		 3.85 4.37 7.18 8.20
Net Nonoperating Obligations (NNO)		 0.00 0.00 -206 -169
Total Depreciation and Amortization (D&A)		 0.00 0.02 0.00 0.19
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.20 $0.37
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 27.65M 32.66M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.20 $0.36
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 27.77M 33.26M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 32.66M 32.66M
Normalized Net Operating Profit after Tax (NOPAT)		 10 13 13 20
Normalized NOPAT Margin		 15.90% 17.19% 12.85% 17.38%
Pre Tax Income Margin		 12.93% 14.80% 7.49% 13.55%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 0.00 0.00 34.08 63.78
NOPAT to Interest Expense		 0.00 0.00 56.75 80.53
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 59.79
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 76.54
Payout Ratios		 - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Bowhead Specialty's Financials

When does Bowhead Specialty's financial year end?

According to the most recent income statement we have on file, Bowhead Specialty's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Bowhead Specialty's net income changed over the last 2 years?

Bowhead Specialty's net income appears to be on an upward trend, with a most recent value of $38.24 million in 2024, rising from $11.26 million in 2022. The previous period was $25.05 million in 2023. Find out what analysts predict for Bowhead Specialty in the coming months.

What is Bowhead Specialty's operating income?
Bowhead Specialty's total operating income in 2024 was $88.45 million, based on the following breakdown:
  • Total Gross Profit: $177.56 million
  • Total Operating Expenses: $89.11 million
How has Bowhead Specialty revenue changed over the last 2 years?

Over the last 2 years, Bowhead Specialty's total revenue changed from $187.60 million in 2022 to $425.66 million in 2024, a change of 126.9%.

How much debt does Bowhead Specialty have?

Bowhead Specialty's total liabilities were at $1.28 billion at the end of 2024, a 53.6% increase from 2023, and a 53.6% increase since 2023.

How much cash does Bowhead Specialty have?

In the past 1 years, Bowhead Specialty's cash and equivalents has ranged from $97.48 million in 2024 to $118.07 million in 2023, and is currently $97.48 million as of their latest financial filing in 2024.

How has Bowhead Specialty's book value per share changed over the last 2 years?

Over the last 2 years, Bowhead Specialty's book value per share changed from 0.00 in 2022 to 11.33 in 2024, a change of 1,133.5%.


Related Companies

This page (NYSE:BOW) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
Shocking AI play that’s beats Nvidia by a country mile
You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...
Timothy Sykes | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Will May start the next "Great Depression?"
You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...
Behind the Markets | Sponsored
🥾⛏️👷‍♂️ What I Learned From Numerous Mine Visits...
Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...
Golden Portfolio | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
The July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...
Crypto Swap Profits | Sponsored
Trump to solve American wealth loss?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored